DOYLESTOWN, Pa., Aug. 16, 2017 -- Alamo Pharma Services, an established leader in attracting exceptional talent in the pharmaceutical and biotech industries, has formed a specialized division of the company that offers partner organizations recruiting services to place the right people with the right attitude and the right talent in the right position within the client company.
|
||||||||
“The investment companies make in bringing products to market is not fully realized until they put that product in the best position to be promoted to healthcare providers,” says Amy Peek, Alamo’s Executive Director, Talent Management and Growth. “Alamo can help in all aspects of recruitment to ensure that our clients have the representatives and sales leaders they need to increase sales and maximize their brand’s opportunity.”
Alamo’s recruiting experts work side by side with clients to provide a thoughtful, customized approach that follows behavioral models to ensure that the new hire is a perfect fit for both the job and company’s culture. Like any true partner, Alamo Recruitment Services stays integrally involved in the onboarding of new talent – a key step in boosting profitability and escalating growth.
“The foundation of pharmaceutical and biotech commercial organizations is its sales team,” says Peter Marchesini, Alamo Chief Operating Officer. “Establishing a best-in-class talent acquisition process ensures that you are getting the best possible person for your sales team. Alamo has an exceptional group of recruiting professionals in place who understand and embrace the challenges of today’s market. They are acutely knowledgeable about the pharmaceutical sales industry to better ensure successful results, not only to fill a role but for long-term success.”
Companies seeking a customized talent acquisition organization to attract and retain exceptional talent in the consistently changing pharmaceutical and biotech industries are encouraged to contact Alamo Recruitment Services via email at [email protected].
About Alamo Pharma Services
Founded in 2011, Alamo Pharma Services offers pharmaceutical and biotech companies vital solutions to bring their products to market efficiently and successfully. Based out of its offices in Doylestown, Pa., Alamo offers companies vast commercialization experience, customized recruiting of sales teams, superior training, and committed support services. For more information regarding Alamo, visit AlamoPharmaServices.com or email [email protected].
Alamo is a part of the Mission Family of Companies, a collection of wholly-owned subsidiaries created to diversify offerings and build forward-thinking partnerships with other pharmaceutical and biotech companies. Each company functions independently while their product and service offerings can be linked together to offer customizable solutions to a wide array of outside companies. Other Mission companies include BioComp Pharma, Inc., a generic drug marketer; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a prescription and esthetic dermatology company; as well as BexR Logistix, LLC and their subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of Mission. To learn more, please visit missionfamilyofcompanies.com.
# # #
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/410950d3-5bb5-45f6-a201-919dd23293ce
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b2bab804-58fa-4995-bdc8-205903e97bba
Drew Deeter Alamo Pharma Services 215.348.3890 [email protected]


Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



